- Home
- LTRN vs CRIS Comparison
LTRN vs CRIS Comparison
Compare LTRN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- CRIS
- Stock Information
- Founded
- LTRN 2013
- CRIS 2000
- Country
- LTRN United States
- CRIS United States
- Employees
- LTRN N/A
- CRIS N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTRN Health Care
- CRIS Health Care
- Exchange
- LTRN Nasdaq
- CRIS Nasdaq
- Market Cap
- LTRN 36.0M
- CRIS 21.3M
- IPO Year
- LTRN 2020
- CRIS 2000
- Fundamental
- Price
- LTRN $3.74
- CRIS $1.81
- Analyst Decision
- LTRN Strong Buy
- CRIS Strong Buy
- Analyst Count
- LTRN 1
- CRIS 2
- Target Price
- LTRN $25.00
- CRIS $16.50
- AVG Volume (30 Days)
- LTRN 281.3K
- CRIS 163.8K
- Earning Date
- LTRN 08-07-2025
- CRIS 07-31-2025
- Dividend Yield
- LTRN N/A
- CRIS N/A
- EPS Growth
- LTRN N/A
- CRIS N/A
- EPS
- LTRN N/A
- CRIS N/A
- Revenue
- LTRN N/A
- CRIS $11,202,000.00
- Revenue This Year
- LTRN N/A
- CRIS N/A
- Revenue Next Year
- LTRN N/A
- CRIS $10.67
- P/E Ratio
- LTRN N/A
- CRIS N/A
- Revenue Growth
- LTRN N/A
- CRIS 14.17
- 52 Week Low
- LTRN $2.55
- CRIS $1.02
- 52 Week High
- LTRN $6.12
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- LTRN 63.62
- CRIS 43.58
- Support Level
- LTRN $3.21
- CRIS $1.50
- Resistance Level
- LTRN $3.75
- CRIS $1.98
- Average True Range (ATR)
- LTRN 0.24
- CRIS 0.19
- MACD
- LTRN 0.07
- CRIS -0.05
- Stochastic Oscillator
- LTRN 98.65
- CRIS 43.88
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.